NDMA - Leading Justice

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims

Product Liability / July 24, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDEA, NDMA, product liability lawsuit, prostate cancer, side effects, stomach cancer, valsartan, valsartan MDL, valsartan recall, valsartan settlement, valsartan update

Lawsuits over the alleged link between valsartan and cancer have raised serious concerns about the safety of this widely prescribed blood pressure medication. Reports of contamination with N-nitrosodimethylamine (NDMA), a potential carcinogen, have led to widespread recalls and a surge in legal claims. Patients who relied on valsartan, an angiotensin II receptor blocker (ARB), now […]

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims Read More »

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers

Product Liability / June 24, 2024 / 3 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDEA, NDMA, prostate cancer, side effects, stomach cancer, valsartan, valsartan recall, valsartan settlement

In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was tainted with carcinogenic impurities. This settlement, overseen by U.S. District Court Judge Renée M. Bumb in New Jersey, aims to provide relief to a subset

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers Read More »

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

Product Liability / June 13, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDMA, prostate cancer, settlement, settlement agreement, side effects, stomach cancer, valsartan, valsartan recall, valsartan settlement

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs,

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial

Product Liability / April 12, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDMA, prostate cancer, side effects, stomach cancer, valsartan, valsartan recall

More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic blood pressure drug. Over 1,200 valsartan lawsuits have been filed, with individuals alleging that changes to the manufacturing process resulted in the distribution of valsartan

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »

FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market

Personal Injury / September 19, 2023 / 4 minutes of reading / By Andrew Sarski / cancer lawsuit, carcinogenic, NDMA, ranitidine, zantac, zantac cancer lawsuit, zantac lawsuit, zantac recall

The U.S. Food and Drug Administration (FDA) announced this week that it is asking manufacturers of Zantac and generic ranitidine products to withdraw all prescription and over-the-counter (OTC) versions of the drug from the market immediately. The FDA’s decision is the latest step in an ongoing investigation into the presence of a carcinogenic chemical called

FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market Read More »

Lawsuit Alleges Side Effects of Zantac Caused Prostate Cancer Diagnosis

Personal Injury / November 6, 2023 / 4 minutes of reading / By Andrew Sarski / cancer lawsuit, carcinogenic, heartburn drug, NDMA, ranitidine, zantac, zantac lawsuit

A new product liability lawsuit filed in federal court in Alabama alleges that side effects of the popular heartburn drug Zantac exposed an Alabama man to carcinogenic chemicals for years, ultimately leading to his prostate cancer diagnosis. Based on recent testing by an independent laboratory and widespread drug recalls affecting nearly every version of Zantac

Lawsuit Alleges Side Effects of Zantac Caused Prostate Cancer Diagnosis Read More »

Get A Free Consultation

Personal Injury Lawsuits

Lawsuit Consultation